Optum Now Review

Optum Now — Provider Profile

Overview

Optum Now is the direct-to-consumer virtual care platform operated by Optum, the healthcare services division of UnitedHealth Group (NYSE: UNH) — the largest health insurer in the United States. The virtual care platform launched in 2023, with weight management services added in 2024. Unlike most telehealth GLP-1 startups, Optum Now takes an insurance-first, brand-name-only approach: no compounded medications, no cash-pay shortcuts.

April 2026 context: This provider is active and prescribing brand-name GLP-1 medications. Orforglipron (Eli Lilly oral GLP-1) is not yet FDA-approved — PDUFA date April 10, 2026. Medicare GLP-1 Bridge coverage for obesity is pending; not yet in effect. Compounded semaglutide supply is declining under FDA enforcement pressure.

This matters because Optum Now sits inside a uniquely vertically integrated healthcare conglomerate. UnitedHealth Group owns UnitedHealthcare (insurance), Optum (care delivery and analytics), and OptumRx (pharmacy benefit manager). For UHC members, this can mean smoother prior authorizations and tighter coordination. For everyone else, it means navigating a platform built primarily around insurance coverage — which is a real advantage if you have good coverage and a real limitation if you don't.

It is worth noting that UnitedHealthcare has faced ongoing criticism over prior authorization denial rates. Patients should be aware that the same corporate parent controlling the insurance, the PBM, and now the prescribing platform introduces conflicts of interest that other telehealth providers don't have.

Medications Offered

• Wegovy (semaglutide) — GLP-1 receptor agonist, weekly subcutaneous injection, FDA-approved for chronic weight management
• Wegovy HD (semaglutide 7.2mg) — Higher-dose Wegovy formulation (not yet FDA-approved as of April 2026)
• Zepbound (tirzepatide) — Dual GIP/GLP-1 receptor agonist, weekly subcutaneous injection, FDA-approved for chronic weight management
• Orforglipron (oral GLP-1) — Daily oral GLP-1 receptor agonist, $149/mo
• Ozempic (semaglutide) — GLP-1 receptor agonist, FDA-approved for type 2 diabetes (off-label for weight loss)
• Mounjaro (tirzepatide) — Dual GIP/GLP-1 receptor agonist, FDA-approved for type 2 diabetes (off-label for weight loss)

Optum Now does not offer compounded semaglutide, compounded tirzepatide, or other compounded GLP-1 formulations. All medications are brand-name and dispensed through standard pharmacy channels.

Pricing

True monthly cost: For patients with insurance that covers GLP-1 medications, the total out-of-pocket is $45/month plus your medication copay (which varies widely — anywhere from $25 to $500+ depending on your plan). For UnitedHealthcare members with GLP-1 coverage, this can be one of the most affordable paths to brand-name medication.

Without insurance coverage, Optum Now is effectively unaffordable for weight management. Brand-name GLP-1 medications at list price run $1,000+ per month, and there is no compounded alternative available on the platform.

The $45/month unlimited visits model is genuinely good value for patients who need frequent check-ins during titration or who want ongoing behavioral health support — most competitors charge per visit or bundle visit limits into higher-priced tiers.

States Served

Available in all 50 US states. The service is entirely virtual — no in-person visits.

Insurance

• Brand-name GLP-1 medications require insurance coverage for affordability
• Seamless integration for UnitedHealthcare members — claims, prior authorizations, and pharmacy benefits are handled within the same corporate ecosystem
• Accepts other major insurance plans beyond UHC
• HSA/FSA cards accepted
• OptumRx (UnitedHealth Group's PBM) handles pharmacy benefits for many UHC plans, which can simplify medication access
• No compounded medications available, so there is no cash-pay medication option

Consultation Process

Model: Video consultations with licensed providers.

1. Create an account and complete a health intake covering weight history, medical conditions, current medications, and goals
2. Schedule a video consultation with a licensed provider
3. Provider evaluates eligibility for GLP-1 medication and discusses treatment options
4. If prescribed, medication is routed through your insurance and pharmacy — lab work can be ordered through Optum Now's Quest Diagnostics partnership
5. Ongoing virtual follow-ups included in your $45/month membership — no per-visit charges
6. Behavioral health support available through Optum's behavioral health network if needed

The video-based consultation model is standard for this tier of service. The unlimited visit structure is a meaningful differentiator — patients can schedule follow-ups during titration without worrying about additional costs.

Pros

• $45/month unlimited virtual visits — strong value for patients needing frequent check-ins
• Available in all 50 states
• Video consultations (not async-only)
• Deep integration with UnitedHealthcare for seamless insurance coordination
• Lab ordering available through Quest Diagnostics partnership
• Behavioral health network access for patients who need psychological support alongside weight management
• Backed by the largest US health insurer — no concerns about company stability or funding

Cons

• No compounded GLP-1 options — brand-name only, which means patients without insurance coverage face prohibitive medication costs
• Not a specialized obesity medicine practice — providers are general virtual care clinicians, not necessarily board-certified in obesity medicine
• Tied to the UnitedHealth Group ecosystem, which has faced criticism over prior authorization denial rates and conflicts of interest across insurance, PBM, and care delivery
• Relatively new to weight management (added 2024) — less track record than dedicated weight loss platforms
• No in-person option for patients who prefer or need hands-on clinical evaluation
• Vertical integration cuts both ways — the same company that prescribes the medication also controls insurance approval and pharmacy benefits for many patients

Best For

Patients who already have insurance coverage for brand-name GLP-1 medications — especially UnitedHealthcare members. The $45/month unlimited visits model is hard to beat for patients who want ongoing video-based support without per-visit fees, and the UHC integration eliminates friction that other platforms can't. If your insurance covers Wegovy or Zepbound and you want a straightforward, corporate-backed telehealth experience, Optum Now is a logical choice.

This is not the right platform for patients without GLP-1 insurance coverage, patients seeking compounded alternatives, or patients who want specialized obesity medicine care from dedicated weight management clinicians.

Editorial Verdict

Optum Now's value proposition is simple: if you have good insurance — particularly UnitedHealthcare — it offers an affordable, stable, nationwide path to brand-name GLP-1 medications with unlimited virtual visits for $45/month. That combination of low membership cost, unlimited check-ins, and seamless insurance integration is genuinely competitive.

The limitations are equally clear. Without insurance coverage for GLP-1 medications, Optum Now offers no affordable path to treatment. There are no compounded alternatives, no cash-pay medication options, and no workaround for patients whose plans deny coverage. In a market where compounded semaglutide is available for $99–$199/month from competitors like Mochi Health, Ro, and Henry Meds, the brand-only approach leaves a large segment of patients with no viable option on this platform.

The vertical integration question is real but hard to evaluate from the outside. UnitedHealth Group controlling the insurance, the PBM, and the prescribing platform creates theoretical efficiency gains and theoretical conflicts of interest. We have no evidence that Optum Now patients face different prior authorization outcomes than patients using other telehealth platforms — but the structural incentives are worth understanding.

For the right patient — insured, especially with UHC, wanting brand-name medication and frequent virtual support — Optum Now is a strong, low-cost option. For everyone else, the specialized telehealth platforms offer more flexibility.

Related Content

• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• GLP-1 Cost & Insurance FAQ — What you'll actually pay
• Compounded vs Brand-Name GLP-1s — Understanding the difference